Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection?

✍ Scribed by Shunsuke Mori; Mineharu Sugimoto

• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 319 KB
• Volume: 31
• Category: Article
• ISSN: 0770-3198
• DOI: 10.1007/s10067-011-1902-3